StockData
Mesoblast Ltd logo

Mesoblast Ltd (MESO) bonds

MESONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as MEOBF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Aug 27, 2026Score 6/30
$11.91−0.54 (-4.34%)

Close on Nov 17, 2026Market cap $1.54BP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$129.83M
$21.19M due within a year
Net debt
$26.92M
After $102.91M of cash
Implied interest rate
15.59%
FY2026 interest ÷ average debt
Interest coverage
–
FY2026 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Notes and loans outstanding

Individual notes, bonds and loans

Mesoblast's filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.

See a number that looks wrong?